Challenges in Adopting Level 1 Evidence for Multiparametric Magnetic Resonance Imaging as a Biomarker for Prostate Cancer Screening
Author:
Affiliation:
1. Department of Urology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York
2. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York
Publisher
American Medical Association (AMA)
Subject
Oncology,Cancer Research
Reference8 articles.
1. MRI-targeted or standard biopsy for prostate-cancer diagnosis.;Kasivisvanathan;N Engl J Med,2018
2. What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate cancer at biopsy? a systematic review and meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.;Moldovan;Eur Urol,2017
3. Risk of prostate cancer diagnosis and mortality in men with a benign initial transrectal ultrasound-guided biopsy set: a population-based study.;Klemann;Lancet Oncol,2017
4. Projections of the cost of cancer care in the United States: 2010-2020.;Mariotto;J Natl Cancer Inst,2011
5. Prostate MRI: access to and current practice of prostate MRI in the United States.;Leake;J Am Coll Radiol,2014
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development of an effective predictive screening tool for prostate cancer using the ClarityDX machine learning platform;npj Digital Medicine;2024-06-20
2. PI-RADS v2.1 and PSAD for the prediction of clinically significant prostate cancer among patients with PSA levels of 4–10 ng/ml;Scientific Reports;2024-03-19
3. Utilization trend of prebiopsy multiparametric magnetic resonance imaging and its impact on prostate cancer detection: Real‐world insights from a high‐volume center in southwest China;The Prostate;2024-01-03
4. Clinical value of prostate health index as an indicator for recommending magnetic resonance imaging in patients with gray-zone prostate-specific antigen level;World Journal of Urology;2023-10-04
5. Development and validation of a nomogram based on biparametric MRI PI-RADS v2.1 and clinical parameters to avoid unnecessary prostate biopsies;BMC Medical Imaging;2023-08-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3